147 related articles for article (PubMed ID: 38408865)
1. Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis.
Fan X; He W; Zhang Q; Zhang B; Dong L; Li L; Liu X
Cancer Control; 2024; 31():10732748241232324. PubMed ID: 38408865
[TBL] [Abstract][Full Text] [Related]
2. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts.
Coker AL; Du XL; Fang S; Eggleston KS
Gynecol Oncol; 2006 Aug; 102(2):278-84. PubMed ID: 16434087
[TBL] [Abstract][Full Text] [Related]
4. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
Beavis AL; Gravitt PE; Rositch AF
Cancer; 2017 May; 123(6):1044-1050. PubMed ID: 28112816
[TBL] [Abstract][Full Text] [Related]
5. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.
Rositch AF; Nowak RG; Gravitt PE
Cancer; 2014 Jul; 120(13):2032-8. PubMed ID: 24821088
[TBL] [Abstract][Full Text] [Related]
6. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000.
Singh GK; Miller BA; Hankey BF; Edwards BK
Cancer; 2004 Sep; 101(5):1051-7. PubMed ID: 15329915
[TBL] [Abstract][Full Text] [Related]
7. Real-World Study of the Incidence, Risk Factors, and Prognostic Factors Associated with Bone Metastases in Women with Uterine Cervical Cancer Using Surveillance, Epidemiology, and End Results (SEER) Data Analysis.
Zhang Y; Guo X; Wang G; Ma W; Liu R; Han X; Li L; Baklaushev VP; Bryukhovetskiy AS; Wang W; Wang X; Zhang C
Med Sci Monit; 2018 Sep; 24():6387-6397. PubMed ID: 30207328
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data.
Patel DA; Barnholtz-Sloan JS; Patel MK; Malone JM; Chuba PJ; Schwartz K
Gynecol Oncol; 2005 May; 97(2):550-8. PubMed ID: 15863159
[TBL] [Abstract][Full Text] [Related]
9. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
Yoo W; Kim S; Huh WK; Dilley S; Coughlin SS; Partridge EE; Chung Y; Dicks V; Lee JK; Bae S
PLoS One; 2017; 12(2):e0172548. PubMed ID: 28234949
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015.
Du S; Zhong Y; Zheng S; Lyu J
Cancer Control; 2022; 29():10732748221121226. PubMed ID: 35981235
[TBL] [Abstract][Full Text] [Related]
13. Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis.
Zheng S; Yu H; Zheng X; Wu UT; Ming WK; Huang H; Song J; Zhang X; Lyu J; Deng L
Front Endocrinol (Lausanne); 2023; 14():1238086. PubMed ID: 38125787
[TBL] [Abstract][Full Text] [Related]
14. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
16. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
17. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
18. Cervical Cancer Among Older Women: Analyses of Surveillance, Epidemiology and End Results Program Data.
Quick AM; Krok-Schoen JL; Stephens JA; Fisher JL
Cancer Control; 2020; 27(1):1073274820979590. PubMed ID: 33291971
[TBL] [Abstract][Full Text] [Related]
19. Regional and racial disparities in breast cancer-specific mortality.
Grann V; Troxel AB; Zojwalla N; Hershman D; Glied SA; Jacobson JS
Soc Sci Med; 2006 Jan; 62(2):337-47. PubMed ID: 16051406
[TBL] [Abstract][Full Text] [Related]
20. Improved estimates of cancer-specific survival rates from population-based data.
Howlader N; Ries LA; Mariotto AB; Reichman ME; Ruhl J; Cronin KA
J Natl Cancer Inst; 2010 Oct; 102(20):1584-98. PubMed ID: 20937991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
